Tiansheng Pharmaceutical Group Co., Ltd. (002872.SZ)
CNY 3.94
(0.77%)
CNY 3.94
(0.77%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 350.54 Million CNY | -17.28% |
| 2022 | 407.8 Million CNY | 20.88% |
| 2021 | 337.36 Million CNY | -24.3% |
| 2020 | 445.65 Million CNY | -22.34% |
| 2019 | 573.83 Million CNY | 13.47% |
| 2018 | 505.71 Million CNY | 61.72% |
| 2017 | 312.71 Million CNY | -2.63% |
| 2016 | 321.15 Million CNY | 19.24% |
| 2015 | 269.34 Million CNY | 10.89% |
| 2014 | 242.89 Million CNY | 3.66% |
| 2013 | 234.33 Million CNY | 41.87% |
| 2012 | 165.17 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 62.6 Million CNY | -30.25% |
| 2024 Q1 | 89.96 Million CNY | 9.45% |
| 2024 Q2 | 65.55 Million CNY | -27.14% |
| 2023 Q1 | 89.06 Million CNY | -23.48% |
| 2023 FY | 337.33 Million CNY | -17.28% |
| 2023 Q2 | 96.83 Million CNY | 8.72% |
| 2023 Q3 | 69.24 Million CNY | -28.5% |
| 2023 Q4 | 82.19 Million CNY | 18.71% |
| 2022 Q4 | 116.39 Million CNY | 23.33% |
| 2022 FY | 407.8 Million CNY | 20.88% |
| 2022 Q3 | 94.37 Million CNY | -5.35% |
| 2022 Q2 | 99.71 Million CNY | 2.46% |
| 2022 Q1 | 97.31 Million CNY | 142.78% |
| 2021 Q1 | 121.09 Million CNY | -14.12% |
| 2021 Q4 | 40.08 Million CNY | -51.64% |
| 2021 Q2 | 93.3 Million CNY | -22.95% |
| 2021 FY | 337.36 Million CNY | -24.3% |
| 2021 Q3 | 82.89 Million CNY | -11.16% |
| 2020 Q2 | 127.74 Million CNY | 48.69% |
| 2020 FY | 445.65 Million CNY | -22.34% |
| 2020 Q4 | 140.99 Million CNY | 54.94% |
| 2020 Q3 | 90.99 Million CNY | -28.77% |
| 2020 Q1 | 85.91 Million CNY | -58.67% |
| 2019 Q4 | 207.85 Million CNY | 35.78% |
| 2019 Q3 | 153.08 Million CNY | 37.14% |
| 2019 Q2 | 111.62 Million CNY | 10.22% |
| 2019 Q1 | 101.27 Million CNY | -60.21% |
| 2019 FY | 573.83 Million CNY | 13.47% |
| 2018 Q2 | 95.52 Million CNY | 54.0% |
| 2018 Q3 | 93.62 Million CNY | -1.99% |
| 2018 Q4 | 254.54 Million CNY | 171.88% |
| 2018 FY | 505.71 Million CNY | 61.72% |
| 2018 Q1 | 62.02 Million CNY | -6.31% |
| 2017 Q1 | -471.8 Million CNY | -616.08% |
| 2017 FY | 312.71 Million CNY | -2.63% |
| 2017 Q4 | 66.2 Million CNY | -13.52% |
| 2017 Q3 | 76.56 Million CNY | 115.14% |
| 2017 Q2 | -505.83 Million CNY | -7.21% |
| 2016 Q3 | 75.85 Million CNY | 116.3% |
| 2016 FY | 321.15 Million CNY | 19.24% |
| 2016 Q4 | 91.42 Million CNY | 20.52% |
| 2016 Q2 | -465.37 Million CNY | -7.12% |
| 2016 Q1 | -434.42 Million CNY | 0.0% |
| 2015 FY | 269.34 Million CNY | 10.89% |
| 2014 FY | 242.89 Million CNY | 3.66% |
| 2013 FY | 234.33 Million CNY | 41.87% |
| 2012 FY | 165.17 Million CNY | 0.0% |